Valuation: Neuland Laboratories Limited

Market Cap 29TCr 305.86Cr 266.71Cr 251.84Cr 228.69Cr 428.47Cr 430.26Cr 3.02TCr 1.16TCr 15TCr 1.15TCr 1.12TCr 48TCr P/E 2027 *
61.4x
P/E 2028 * 47x
Enterprise Value 30TCr 308.53Cr 269.04Cr 254.04Cr 230.68Cr 432.21Cr 434.01Cr 3.04TCr 1.17TCr 15TCr 1.16TCr 1.13TCr 48TCr EV / Sales 2027 *
12.1x
EV / Sales 2028 * 10.1x
Free-Float
62.26%
Yield 2027 *
0.1%
Yield 2028 * 0.13%
1 day+0.97%
1 week-3.90%
Current month-0.26%
1 month-3.37%
3 months+34.56%
6 months+86.39%
Current year+50.59%
1 week 21,858.35
Extreme 21858.35
23,426.8
1 month 21,858.35
Extreme 21858.35
24,235.05
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 3,528
Extreme 3528
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%-3.90%+41.70%+521.51% 303.51Cr
-0.89%+2.53%+49.94%+100.25% 1,02700Cr
-0.14%+1.64%+54.99%+66.14% 65TCr
-0.03%+2.76%+19.02%+71.63% 47TCr
-1.22%+3.66%+36.44%+38.32% 35TCr
-0.79%+2.73%+19.03%+25.08% 27TCr
+0.58%+6.76%+11.13%+16.52% 26TCr
+0.78%+1.48%+38.83%+45.52% 21TCr
+0.79%+1.84%-28.27%-56.71% 19TCr
-0.25%+4.79%+32.56%+99.17% 19TCr
Average -0.06%+1.76%+27.54%+92.74% 36.05TCr
Weighted average by Cap. -0.37%+2.62%+34.82%+61.74%

Financials

2027 *2028 *
Net sales 2.44TCr 25Cr 22Cr 21Cr 19Cr 36Cr 36Cr 251.16Cr 97Cr 1.24TCr 96Cr 94Cr 4TCr 2.93TCr 30Cr 27Cr 25Cr 23Cr 43Cr 43Cr 300.81Cr 116.08Cr 1.49TCr 114.57Cr 112.03Cr 4.79TCr
Net income 479.83Cr 5Cr 4.36Cr 4.12Cr 3.74Cr 7.01Cr 7.03Cr 49Cr 19Cr 243.95Cr 19Cr 18Cr 784.95Cr 626.47Cr 6.53Cr 5.69Cr 5.38Cr 4.88Cr 9.15Cr 9.18Cr 64Cr 25Cr 318.5Cr 25Cr 24Cr 1.02TCr
Net Debt 256.12Cr 2.67Cr 2.33Cr 2.2Cr 2Cr 3.74Cr 3.75Cr 26Cr 10Cr 130.21Cr 10Cr 9.8Cr 418.98Cr 98Cr 1.02Cr 89L 84.04L 76.31L 1.43Cr 1.44Cr 10Cr 3.88Cr 50Cr 3.83Cr 3.75Cr 160.21Cr
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
18/26/18 22,875.70 +0.97% 4,026
17/26/17 ₹22,656.20 +0.01% 1,356
16/26/16 ₹22,653.10 +0.58% 2,147
15/26/15 ₹22,522.85 -4.31% 2,850
11/26/11 ₹23,536.20 -1.12% 2,445
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
22,875.70INR
Average target price
24,334.75INR
Spread / Average Target
+6.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!